Multifactor dimensionality reduction for detecting gene–gene and gene–environment interactions in pharmacogenomics studies

Author： Ritchie Marylyn D   Motsinger Alison A  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.6, Iss.8, 2005-12, pp. : 823-834

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A Bayesian approach to gene––gene and gene––environment interactions in chronic fatigue syndrome

By Lin Eugene   Hsu Sen-Yen  

Pharmacogenomics, Vol. 10, Iss. 1, 2009-01 ,pp. : 35-42

Future Medicine

Access to resources Recommend Favorite

Gene-Gene Interactions in a Context of Individual Variability in Antipsychotic Drug Pharmacogenomics

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 4, 2011-12 ,pp. : 323-331

Bentham Science Publishers

Access to resources Recommend Favorite

Human Health Implications Arising from Gene-Environment Interactions Studies in China

By Zhou Jian-Wei   Wang Xin-Ru  

Journal of Toxicology and Environmental Health, Vol. 70, Iss. 11, 2007-01 ,pp. : 875-875

Taylor & Francis Ltd

Access to resources Recommend Favorite

Gene-environment interactions of selected pharmacogenes in arterial hypertension

By Bochud Murielle   Guessous Idris  

Expert Review of Clinical Pharmacology, Vol. 5, Iss. 6, 2012-11 ,pp. : 677-686

Informa Healthcare

Access to resources Recommend Favorite

Risk and Protective Effects of the Complexin-2 Gene and Gene-Environment Interactions in Schizophrenia

By  

Recent Advances in DNA & Gene Sequences (Formerly Recent Patents on DNA & Gene Sequences), Vol. 8, Iss. 1, 2014-06 ,pp. : 30-34

Bentham Science Publishers

Access to resources Recommend Favorite